ZBIO
Zenas Biopharma Inc
NASDAQ · Biotechnology
$21.80
+0.79 (+3.76%)
Open$21.48
Previous Close$21.01
Day High$22.43
Day Low$20.91
52W High$44.60
52W Low$6.11
Volume—
Avg Volume682.3K
Market Cap1.19B
P/E Ratio—
EPS$-12.67
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+35.4% upside
Current
$21.80
$21.80
Target
$29.51
$29.51
$22.12
$29.51 avg
$35.27
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.69M | 140.52M | 130.81M |
| Net Income | -649,730,155 | -116,113 | -126,311 |
| Profit Margin | -3,139.8% | -0.1% | -0.1% |
| EBITDA | -647,386,669 | -178,287 | -168,053 |
| Free Cash Flow | — | -139,366 | -118,293 |
| Rev Growth | — | -3.7% | +16.0% |
| Debt/Equity | — | 0.89 | 0.92 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |